CELC
Price
$72.17
Change
-$2.96 (-3.94%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
3.9B
47 days until earnings call
Intraday BUY SELL Signals
WHWK
Price
$3.70
Change
-$0.06 (-1.60%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
214.35M
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CELC vs WHWK

CELC vs WHWK Comparison Chart in %
View a ticker or compare two or three
VS
CELC vs. WHWK commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Hold and WHWK is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
CELC vs WHWK: Fundamental Ratings
CELC
WHWK
OUTLOOK RATING
1..100
8724
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
55100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6146
P/E GROWTH RATING
1..100
10035
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WHWK's Valuation (65) in the Pharmaceuticals Major industry is in the same range as CELC (83) in the Miscellaneous Commercial Services industry. This means that WHWK’s stock grew similarly to CELC’s over the last 12 months.

CELC's Profit vs Risk Rating (55) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for WHWK (100) in the Pharmaceuticals Major industry. This means that CELC’s stock grew somewhat faster than WHWK’s over the last 12 months.

WHWK's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as CELC (100) in the Miscellaneous Commercial Services industry. This means that WHWK’s stock grew similarly to CELC’s over the last 12 months.

WHWK's Price Growth Rating (46) in the Pharmaceuticals Major industry is in the same range as CELC (61) in the Miscellaneous Commercial Services industry. This means that WHWK’s stock grew similarly to CELC’s over the last 12 months.

WHWK's P/E Growth Rating (35) in the Pharmaceuticals Major industry is somewhat better than the same rating for CELC (100) in the Miscellaneous Commercial Services industry. This means that WHWK’s stock grew somewhat faster than CELC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CELCWHWK
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 15 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 23 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
80%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (CELC: $75.13 vs. WHWK: $3.76)
Brand notoriety: CELC and WHWK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 111% vs. WHWK: 51%
Market capitalization -- CELC: $3.9B vs. WHWK: $214.35M
CELC [@Biotechnology] is valued at $3.9B. WHWK’s [@Biotechnology] market capitalization is $214.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 0 FA rating(s) are green while WHWK’s FA Score has 0 green FA rating(s).

  • CELC’s FA Score: 0 green, 5 red.
  • WHWK’s FA Score: 0 green, 5 red.
According to our system of comparison, WHWK is a better buy in the long-term than CELC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 4 TA indicator(s) are bullish while WHWK’s TA Score has 4 bullish TA indicator(s).

  • CELC’s TA Score: 4 bullish, 4 bearish.
  • WHWK’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CELC is a better buy in the short-term than WHWK.

Price Growth

CELC (@Biotechnology) experienced а -5.34% price change this week, while WHWK (@Biotechnology) price change was -2.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

CELC is expected to report earnings on Nov 18, 2026.

WHWK is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CELC
Daily Signal:
Gain/Loss:
WHWK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MNRS38.56N/A
N/A
Grayscale Bitcoin Miners ETF
SEEM38.74-0.04
-0.10%
SEI Select Emerging Markets Equity ETF (SEEM)
ONLN54.14-0.07
-0.13%
ProShares Online Retail ETF (ONLN)
NRO2.58-0.02
-0.77%
Neuberger Real Estate Securities Income Fund Inc.
GDXJ112.46-1.49
-1.31%
VanEck Junior Gold Miners ETF (GDXJ)

WHWK and

Correlation & Price change

A.I.dvisor indicates that over the last year, WHWK has been loosely correlated with AXON. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if WHWK jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WHWK
1D Price
Change %
WHWK100%
N/A
AXON - WHWK
44%
Loosely correlated
-0.07%
CCCC - WHWK
38%
Loosely correlated
-5.71%
AMRN - WHWK
37%
Loosely correlated
-2.15%
CELC - WHWK
37%
Loosely correlated
-5.52%
PRQR - WHWK
37%
Loosely correlated
-1.81%
More